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Abstract and Key Terms
Following injury to the central nervous system, extracellular modulations are apparent at
the site of injury, often resulting in a glial scar. Astrocytes are mechanosensitive cells, which can
create a neuroinhibitory extracellular environment in response to injury. The aim for this
research was to gain a fundamental understanding of the affects a diffuse traumatic brain injury
has on the astrocyte extracellular environment after injury. To accomplish this, a bioreactor
culturing astrocytes in 3D constructs delivered 150G decelerations with 20% biaxial strain to
mimic a traumatic brain injury. Experiments were designed to compare the potential effects of
media type, number of impacts, and impacts with or without strain. Multiple impacts on
astrocytes resulted in increased apoptosis, supporting cumulative effects of multiple traumatic
brain injury events. Surprisingly, the expression of glial fibrillary acidic protein and S100B by
astrocytes was downregulated following injury. With multiple impacts, astrocytes downregulated
collagen and glycosaminoglycan expression at acute time points. Suppression of matrix
metalloproteinase-2 coupled with unchanging production of transforming growth factor beta-1
and tissue inhibitor of metalloproteinase-1 indicates an inability to degrade damaged ECM or
produce new ECM. This was supported by long-term studies which indicate significant decreases
in chondroitin sulfate proteoglycan and collagen I accumulation. This could suggest astrocytes
experiencing damaging mechanical stimulation enter a survival state ceasing to moderate the
extracellular environment at short time points after injury.
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I.

Introduction

Traumatic Brain Injury
Traumatic brain injury (TBI) is described as an alteration of brain pathology caused by an
external force (1). An estimated 1.7 million people in the U.S. experience a TBI annually,
resulting in over 50,000 fatalities; however, the true number could be much larger as not all
individuals that experience a TBI actively seek medical attention (2, 3). The incidence of TBI
appears to have increased in recent years as TBI-related emergency department visits have
increased 29% over a 5 year time span (4). The substantial proportion of the population affected
by TBI creates an economic burden estimated to cost $63.4 billion to $79.1 billion from medical
treatment and lost productivity (5).
TBI can be classified by a variety of parameters given the nature of the injury (blast
injury, closed head injury) and the severity of the injury (mild, moderate, severe) (6). The most
common injury among these is mild traumatic brain injury (mTBI), often called a concussion,
commonly associated with symptoms of headache, dizziness, and confusion acutely following
injury (7). Symptoms can also include decreased cognitive performance (forgetfulness, difficulty
in learning), altered sleep habits, and altered emotional behavior, though symptoms tend to
resolve within 7-10 days (8, 9). Long-term, mTBI has been linked to depression in up to 48% of
patients one year following injury (10). Additionally, chronic traumatic encephalopathy (CTE), a
recently discovered diseased characterized by cognitive deficiencies, volatile emotional
behavior, and motor disease, has been linked to repeated traumatic brain injury (11). One
hypothesized cause bridging the gap from mTBI to CTE are the formation of neurofibrillary
tangles caused by the release of pro-inflammatory cytokines subsequently activating astrocytes
and microglia upon mechanical stimulation (12). CTE is most commonly known from extensive
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media coverage for affecting professional athletes that maintained a career in contact sports,
specifically football; however, the military population suffering repeated blast injuries is an
underreported yet significant demographic affected by traumatic brain injury (13).
Within the civilian population, young adults aged 15 to 24 years and the elderly over the
age of 65 are at the greatest risk of suffering a TBI with the elderly having the highest mortality
rates due to TBI (3). The most common cause of TBI occurs from falls, automobile accidents, or
having the head strike or be struck by another object. Deployed military personnel are also at
greater risks of suffering a TBI, specifically from blast injury, and are at greater risks of poor
psychiatric health often suffering from post-traumatic stress disorder (14). The heterogeneity of
TBI complicates creating an all-encompassing model for injury. It is necessary for models of
TBI to simplify the insult itself to create a platform for replicable injury which can be used to
study the cellular response to TBI (15). To this end, a fundamental study was performed to
evaluate the responses of central nervous system cells to rapid decelerations coupled with biaxial
stretching.
Modeling Traumatic Brain Injury
Expanding our knowledge on the manner physical stimulation is translated into a
biological response will be of vital importance to understand, predict, and treat TBI. Attacking
this issue can be quite difficult; one must understand the mechanical properties of brain tissue,
the nature of the mechanical forces during TBI, and the mechanisms within the cell that sense
and respond to these forces.
The tissue response of the brain to mechanical forces has been observed by performing
mechanical testing on cortical tissue. The brain can be described as a viscoelastic material
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possessing non-linear stress-strain behavior, hysteresis, and changing mechanical properties
depending on strain rate (16). Understanding the mechanical properties of brain tissue can help
produce accurate finite element models that can be used to predict pressures, stresses, and strain
within the brain during TBI (17, 18). The nature of the mechanical stimulation can vary greatly
as no single factor can predict the severity of injury (19). Factors can include rapid linear
accelerations, rotational accelerations, the direction of impact, and impact duration (20). Linear
accelerations have been shown to produce pressures, compression, and stretching which are one
potential pathway to altered biological function. Likewise, rotational accelerations can produce
shearing and stretching of cells inducing an injury response. A threshold level of an 18% stretch
on neurons has been suggested to invoke traumatic axonal injury, though this was performed in
an animal model and may not translate to the human injury tolerance level (21). The findings
from studies investigating biomechanics of head injury creates parameters for in vitro and in vivo
models to replicate.
Methods for modeling TBI in vitro and in vivo have been extensively reviewed (6, 22).
Observing biological phenomena in vitro rarely translate directly to human physiology, therefore
multitudes of animal models have been designed to study TBI in a complex system acting as an
intermediate step. In vivo models for TBI reconstruct the mechanical stimulation of a traumatic
brain injury. The most common TBI model used in animal studies is the fluid percussion injury.
Briefly, this model produces TBI by way of a fluid pressure wave triggered by a weighted
pendulum striking a lateral fluid column propagating the pressure wave onto an exposed surface
of the brain resulting in cognitive and motor defects as well as biomarkers of injury (23). First
reported by Dixon et al., controlled cortical impact is another popular model for TBI utilizing a
piston to strike exposed brain tissue at high rates creating a focal injury that is highly
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reproducible (24, 25). Weight drop models require a substantial mass confined in a guide tube to
be released from a height and strike the animal’s head directly or on a plate covering the head
causing diffuse injury (26, 27). Blast injury models inspired from soldiers exposed to explosions
from the Iraqi and Afghan wars typically require placement of an animal into a metal tube that
carries a pressure wave triggered by air or an explosion down the tube to the exposed animal
(28). Finally, models using angular acceleration as the only means of mechanical stimulation by
sudden twisting of the animal’s head have been reported to cause diffuse brain injury (29).
However, in vivo models suffer in isolating and observing specific biological phenomenon,
controlling and measuring cellular and tissue mechanics, experiencing greater variability animalto-animal, and requiring substantial increases in monetary cost for experiments.
In vitro TBI models are advantageous because of the ability to investigate specific
pathobiological phenomena by tightly controlling experimental variables and mechanical
stimulation. Commonly, in vitro models will utilize primary cultures, mixed cultures, or
organotypic slice cultures (30). Primary cultures allow one to investigate specific pathways and
mechanisms for one cell type while mixed cultures can provide insights into the interplay
between different cells in mounting a response to injury. One common injury model requires the
stretching of cell cultures or organotypic slice cultures on an elastic membrane (31). La Placa
and Thibault developed a model invoking shear stress on neuronal cultures (32). Compression
models have also been developed by dropping weights onto cell cultures (33). The wide plethora
of in vitro TBI models examines specific mechanisms of injury providing specific insights into
an injury response. To this end, we sought to develop an in vitro TBI bioreactor capable of
applying multiple types of mechanical stimulation to primary cultures to increase the knowledge
of the behavior of cells after suffering a traumatic brain injury.
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The Role of Astrocytes in the Central Nervous System
The central nervous system (CNS) remains one of the most complex and least understood
organ systems in the body. The CNS is comprised of the brain and spinal cord and acts as the
integration center for receiving sensory information and transmitting a response to the rest of the
body. Within the parenchyma of the brain and spinal cord, cells can be classified as either
neuronal, endothelial, or glial cells. Neurons function by converting chemical, mechanical, or
temperature stimuli into an electrical signal. The electrical signal known as an action potential is
relayed to other neurons ultimately invoking a cognitive and motor response. Neurons are the
functional cell type within the CNS responsible for our ability to sense our surroundings, form
consciousness and thought, develop emotions, and generate signals for the body’s organs to
function. Endothelial cells create the vascularization within the brain playing a pivotal role of
supplying CNS cells with nutrients and gas transport from the blood while blocking the passage
of large molecules and pathogens. In approximately equal number to neurons is the “glue” of the
brain in glial cells acting to support neuronal health, guide neurons in development, and regulate
synapse formation (34). Glial cells include microglia, oligodendrocytes, and astrocytes.
Microglia act as immune responders to pathogens entering the CNS as well as phagocytes to
remove apoptotic cells. Oligodendrocytes are primarily found within the white matter of the CNS
and are responsible for producing myelin sheath. Myelin created by oligodendrocytes act as an
insulating barrier encircling axons to increase the speed of the action potential. Astrocytes carry
out many essential functions including the production of extracellular matrix within CNS tissue
and is the focus of this research henceforth.
Astrocytes are specialized glial cells responsible for maintaining homeostasis for neurons
critical to survival (35). Astrocytes can be subdivided into two groups; protoplasmic astrocytes
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are located in gray matter rich in neuronal cell bodies while fibrous astrocytes are found in the
white matter where myelinated axons and oligodendrocytes are localized interacting with the
nodes of Ranvier (36). However, the broad grouping of astrocytes into two groups may not be
accurate as growing evidence supports heterogeneity of astrocytes in different regions of the
brain. Astrocytes also bridge the gap between neurons and blood vessels modulating blood flow
to specific regions of the brain by signaling endothelial cells to constrict or dilate controlling
blood flow based on synaptic activity of the neighboring neurons (37). Astrocytes are also
believed to aid in formation of the blood-brain barrier with end-feet coming into direct contact
with endothelial cells (38).
At the synapse of neurons, astrocytes facilitate the recycling of neurotransmitters by
uptaking released neurotransmitters and converting the molecules back to precursors that are
then delivered to the axon terminal to be reused by the neuron (39). Though astrocytes do not
‘fire’ propagating an action potential like neurons, growing evidence indicates astrocytes
participate in passing and modulating signals at the synapse. Known as the ‘tripartite synapse’,
astrocytes possess G protein-coupled receptors that can be activated by neurotransmitters
released from the presynaptic neuron like glutamate causing a rise in calcium levels within the
astrocyte (40, 41). Evidence has shown in response to increased intracellular calcium astrocytes
may release gliotransmitters such as glutamate, GABA, and ATP into the synapse (42). Studying
the tripartite synapse is still in its infancy as many questions remain on the mechanisms involved
in the release of gliotransmitters and if neurons truly respond to gliotransmitters.
Astrocytes are believed to tightly regulate interstitial fluid volume in the brain through
the aquaporin-4 water channel (43). For energy, astrocytes act as the mediator of the uptake of
glucose from the blood stream to neurons. Astrocytes also act to store glycogen that can be
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metabolized and delivered to neurons as lactate during periods of hypoglycemia or localized high
activity (44).
Additionally, astrocytes generate the ECM in the CNS. As in other tissues, the ECM acts
to create structure and provide chemical cues to cells. In development, astrocytes can guide
axons by secreting chondroitin sulfate proteoglycans (CSPGs) and tenascin-C that prevents
axons from growing across these extracellular matrix proteins (45). The ECM of the CNS is
unique in that it lacks the fibrous collagen backbone observed in other tissue’s ECM and instead
creates a mesh of glycoproteins and proteoglycans chiefly relying on hyaluronic acid.
Surrounding blood vessels, astrocytes deposit a basement membrane comprising of laminin,
fibronectin, heparin sulfate proteoglycans (HSPG), and collagen IV functioning to maintain the
blood-brain barrier (46). Within the parenchyma, the most prominent ECM feature are
perineuronal nets localized at synapses. Perineuronal nets are comprised of dense meshwork of
CSPGs, tenascins, and hyaluronic acid and are believed to function to provide structure to the
synapse and allow synaptic plasticity (47). Likewise, the neural interstitial matrix is built by the
same proteoglycans as the perineuronal nets, though are located away from synapses. When
exposed to insult or injury, astrocytes have the capacity to remodel the extracellular environment
to minimize damage to surrounding tissue. It is less understood how astrocytes recognize injury
and what ultimately triggers the remodeling of the ECM following injury.
The Injury Response in the Central Nervous System
Astrocytes are known to respond to any CNS insult like traumatic brain injury, formally
known as reactive gliosis. In vivo and in vitro studies alike have demonstrated astrocytes
proliferating at the site of injury, increase expression of intermediate filaments glial fibrillary
acidic protein (GFAP) and vimentin, and increase expression of chondroitin sulfate
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proteoglycans, laminin, and collagen IV (48-50). With TBI, one potential side effect is increased
cranial pressure caused by edema in the brain. As mentioned previously, astrocytes tightly
regulate the volume of interstitial fluid within the brain. Upon injury, research suggest astrocytes
swell within hours causing an increase intracranial pressure with increased pressure correlating
to poorer patient outcomes (51). Swelling has been suggested to be incited by increased
expression of aquaporin-4 water channel as well as the activation of nuclear factor-κB (NF-κB)
(52, 53).
Another known response to traumatic brain injury is the breakdown of the blood-brain
barrier (BBB). Increased permeability of the BBB is an additional source of fluid build-up and
greater intracranial pressure (51). Increased permeability of the BBB allows immunoglobulin G
and albumin pass the BBB causing an inflammatory response in the parenchyma of the CNS
(54). The initiation of an inflammatory response can create a signaling cascade causing the
release of cytokines such as tumor necrosis factor-α and interlukin-1β that are toxic to neurons
and cause reactive gliosis (54). Ultimately, the activation of astrocytes can lead to significant
extracellular changes after injury.
Of particular interest to our group is understanding the extracellular changes driven by
astrocytes which reshape the ECM after sustaining injury. In focal injuries (i.e. penetrating
injuries, gunshot wounds), an evident scar region can form comprised of GFAP-positive
astrocytes producing (CSPGs) in an effort to isolate the injury, thereby limiting the spread of
inflammation and tissue damage. In the short term, this is advantageous for limiting damage to
neighboring healthy tissue; however, the scarred region inhibits long-term neuron growth, thus
preventing the reformation of any neural connections lost during injury. Astrocytes further
modify the extracellular environment with increased expression of fibronectin and laminin
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believed to aid in macrophages clearing dying cells and repair the BBB, respectively (55).
However, in diffuse traumatic brain injury, an injury site and glial scar formation may not be
apparent. A greater understanding of changes in the extracellular environment driven by
astrocytes could provide needed insights into the diagnosis and treatment of TBI. Further, it is
our goal to determine the mechanical mechanisms in which astrocytes sense injury and how
astrocytes may affect the extracellular environment.
Thesis Statement
Previously, we have reported a novel bioreactor capable of delivering mechanical
stimulation mimicking a traumatic brain injury (56). The bioreactor is unique in that it
implements inertial loads onto cells while simultaneously applying biaxial strain. We
hypothesize mechanical stimulation causes fundamental changes in the composition and
production of extracellular matrix proteins by astrocytes at acute time points after a TBI event.
The aims for this project were to first validate the bioreactor mimicked mechanical stimulation
experienced by the brain that results in a traumatic brain injury. Validation of the injury model
was accomplished by observing astrocyte survival and behavior for key markers of reactivity.
Extracellular matrix alterations were observed in astrocyte cultures through monitoring gene
expression, cytokine secretion, and immunofluorescence labeling of structural and adhesion
proteins. The outcome for this study was to observe and present astrocyte behavior and
alterations to the extracellular environment after simultaneous exposure to inertial loads and
stretch analogous to a TBI, while investigating potential cumulative effects with multiple
injuries, and observe changes to the astroglial response to injury when cultured with or without
serum.

9

II.

Material and Methods

TBI Bioreactor Fabrication
The TBI bioreactor used is that which was previously reported by Heller et al. and can be
used for an in depth characterization of the bioreactor (56). The TBI bioreactor contains four
components; a guide rod, drop shuttle, polypropylene cell culture drum and a spring-damped
base. The guide rod is comprised of a steel rod (diameter = 3cm, length 2m) press-fit into an
aluminum base plate (Fig 1A). The guide rod acts to constrict the motion of the drop shuttle to
one vertical direction. The shuttle is made from two aluminum plates encompassing an
intermediate polypropylene plate (Fig 1B). The top aluminum plate has a linear bearing attached
to allow nearly frictionless motion along the guide rod. Six small circular holes were cut from
the polypropylene layer that act to house the cell culture drums during impacts. The bottom
aluminum plate contains six circular holes coincident to the openings in the polypropylene layer
that allow custom indenters to apply biaxial strain to the culture upon impact (Fig 1C).
Increasing the height of the indenter coincides with increased strain on the cell culture. Indenter
heights of 5mm caused 20% biaxial strain on the cell culture. Cell culture drums utilize a porous
polyurethane foam created using a technique familiar to our lab (Fig 2). Wetted sugar was
packed into silicone molds and dried in an oven at 70ºC for 30 minutes. Polyurethane dissolved
in dimethylacetamide (DMAC) (10% weight by volume) was pipetted drop by drop onto the
sugar mold. Polyurethane was cured and sugar dissolved by placing molds in repeated deionized
water baths over three days. Medical grade polydimethylsiloxane (PDMS) placed beneath the
scaffold is secured by a silicone O-ring and creates a watertight seal. The impact base is
comprised of a square steel plate mounted onto an interchangeable spring (Fig 2).

10

Characterization of TBI Bioreactor
A uniaxial ±300G accelerometer was mounted onto the drop shuttle and connected to a
16-bit data acquisition card (National Instruments). Samples were collected at 10,000 Hz. A
custom-built LabVIEW program converted accelerometer voltage output (-2.5V to 2.5V) to
gravitation. The bioreactor was characterized with three different spring bases for impact
duration (n=25) and peak deceleration. A linear relationship for the peak deceleration for each
spring was established by releasing the drop shuttle at 25cm increments up to 175cm above the
spring-damped base (n=5, per height). Biaxial strain was validated optically using a digital
camera and three microspheres as markers. Pre-stretch and post-stretch images were acquired.
Monitoring the change in distance between each microsphere after deformation generated values
for circumferential, radial, and shear strain.
Isolation of primary rat astrocytes
Primary cortical rat astrocytes were isolated from 1-day old neonatal rat pups following a
modified procedure previously reported (57). Rat astrocyte cortexes were separated from all
meninges and blood vessels and digested in dissociation media (0.2% collagenase/DNase) for
two hours. Dissociated cells were treated with 0.25% Trypsin (Gibson), then passed through a
cell strainer. Finally, cells were rinsed and centrifuged in 1X PBS supplemented with glucose.
Mixed glial and neural cells were seeded onto laminin-coated cell culture flasks. Mixed glial
cultures were grown in DMEM F-12 media (Gibco) supplemented with 10% Fetal bovine serum
(FBS), 1% Penicillin/Streptomycin, and 1% l-Glutamine and allowed to reach confluency (7-9
days) with media exchanges occurring every two days. Mixed glial cultures were then subject to
orbital shaking for twenty-four hours at 200 RPM to detach loosely adherent neurons, microglia,
and oligodendrocytes. Purified astrocytes were passaged to culture flasks until the desired cell
11

number was achieved. Astrocyte purification was validated by immunostaining for the presence
of glial fibrillary acidic protein (GFAP), a common marker for astrocytes (Appendix A) (58, 59).
A threshold of 90% GFAP positive cells was used in determining if cultures were astroglial
enriched cultures or mixed glial cultures (60). Cultures were maintained in an incubator at 37°C,
95% humidity, and 5% CO2.
Experimental Design
Astrocyte cultures were divided into multiple subsets to explore potential differences in
cellular response given different culturing parameters. The first parameter explored was the
effect of serum-containing media (10% fetal bovine serum) against serum-free media (N-2
Supplement) (61, 62). The difference in media aimed to mimic an open head injury with the
presence of blood at the injury site against a closed head injury where blood may not be present
throughout the injury. The second parameter compared the reaction of cells to a single TBI
mimetic impact against those receiving a second TBI mimetic impact twenty-four hours after the
first impact. Previous work has shown graded cognitive differences and astroglial reactivity
indicative of a cumulative response to TBI as well as heightened sensitivity to injury shortly after
an initial impact (26, 63, 64). The third parameter evaluated the response of astrocyte cultures to
receiving a 150G impact with 20% biaxial strain against cultures receiving a 150G impact
without strain. To this end, we sought to compare the nature of the stimulus that brought about
reactivity and changes in astrocyte behavior post injury. A total of 8 experimental groups were
tested represented by all combinations of the parameters listed previously (n=4 minimum per
group).
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Mimetic TBI Impacts
Prior to seeding, cell culture drums were incubated in laminin (10ug mL-1, Gibco)
overnight to promote cell adhesion. Astrocytes were seeded onto the center (10mm diameter) of
the fabricated TBI bioreactor drums at a concentration of 4.5×105 cells per drum. Cells were
given seventy-two hours to adhere and proliferate within the drum. Forty-eight hours prior to the
first impact, cultures designated as serum-free were switched to serum-free media. Neurobasal
serum-free media comprised of DMEM/F-12 media with 1% N-2 Supplement (Gibco), 1%
Pen/Strep, and 1% l-Glutamine. Releasing the drop shuttle 170cm above the base corresponded
to a 150G impact. The use of 5mm indenters onto the base of each cell culture provided 20%
biaxial strain. Medium was removed from each cell culture immediately before impact and fresh
medium added immediately following impact. The time out of media was recorded for each
culture, spending a total of 5-7 minutes out of media. A second impact was given twenty-four
hours after the initial impact to cultures designated for that parameter.
Cell Viability Assay
Relative cell viability was established using a modified MTT cell proliferation procedure
(Life Technologies). Cultures received mimetic TBI impacts as described above. Forty-eight
hours following impact, cultures were rinsed with DMEM/F-12 media without phenol red and
incubated in 1mL MTT solution (1.2mM) for two hours. 75% of the solution was aspirated
following incubation and replaced with dimethyl sulfoxide (DMSO). The resulting precipitate
was solubilized by agitation through repeated pipetting. Solution was transferred to a 96 well
plate and absorbance at 540nm was measured (BioTek Synergy Mx). A standard curve was
generated using known cell culture concentrations and experimental results were referenced to
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the standard. Reported cell viability is expressed relative to the single impact, serum-containing
control.
Reverse transcription-PCR (RT-PCR) analysis
Two separate RT-PCR experiments were performed targeting reactive gliosis and
extracellular matrix substrates. Exploring reactive gliosis, extraction of cells from culture for all
experimental groups (n=4-5/group) occurred twenty-four hours following the terminal impact
while for extracellular matrix production extraction occurred six hours following the final impact
for all experimental groups (n=4/group). Cell culture foams were removed from the cell culture
drum using a scalpel and stored in RNAProtect (Qiagen) at -80°C. RNA was isolated using
RNeasy Mini Kit Plus (Qiagen) following manufacturer’s protocol. Genomic DNA was
eliminated by passing RNA through gDNA Eliminator Spin Column (Qiagen) during the RNA
isolation procedure. RNA samples were reverse transcribed using iScript cDNA Synthesis kit
(Bio-Rad) following the manufacturer’s protocol. cDNA samples were appropriately diluted for
RT-PCR analysis so that all samples contained the same concentrations of cDNA. In studying
reactive gliosis, GFAP, S100B, and Vimentin primers were commercially purchased (Bio-Rad).
For extracellular matrix production, primers for Collagen I, Versican, and Neurocan were also
commercially obtained (Bio-Rad). SsoAdvanced Universal Sybr Green Supermix (Bio-Rad)
acted as the fluorescent label to monitor amplification of the target genes. ECM protein
expression was normalized to GAPDH expression relative to the control sample using the ∆∆Ct
method. Cycling conditions were 40 cycles at 95°C for 5 seconds and 60° for 30 seconds
following manufacturer’s recommendations (Bio-Rad CFX96 Touch).
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Extracellular and Inflammatory cytokine analysis
Cell culture supernatants were collected forty-eight hours following the final impact.
Cytokine concentrations from cell culture supernatants were measured using colorimetric
sandwich ELISAs (R&D Systems) for Matrix Metalloproteinase 2 (MMP-2), Tissue Inhibitor of
Metalloproteinases 1 (TIMP-1), and Transforming Growth Factor Beta 1 (TGFβ-1) following the
manufacturer’s protocol. Cytokine concentrations are presented relative to viable cells found
from the MTT assay and reported as production of cytokine per cell (fg cell-1)
Measurement of Matrix Accumulation
To investigate the effect of repeated impact on cellular matrix accumulation, astrocyteseeded porous polyurethane foam culture inserts were impacted (150g combined with 20%
strain) every 2-3 days for a total of three weeks (9 impacts total). The repeated impact regime
was designed to imitate an in-season football training schedule, during which athletes have been
shown to experience up to 900 head impacts. Serum-containing media (10% FBS) was
exchanged every 2-3 days throughout the conditioning period. Following the three-week
conditioning period, impacted and static control samples were fixed in 4% paraformaldehyde,
permeabilized with 0.05% triton and stained for the presence of collagen type I (Sigma 1:500)
laminin, (Sigma 1:1000) and chondroitin sulfate proteoglycan (CSPG, Sigma 1:500) followed by
the appropriate fluorescently labeled secondary detection antibodies (Life Technologies,
Alexafluor, 1:500). The intensity of fluorescence against collagen, laminin, and CSPG for each
sample was used to estimate matrix accumulation. Immunoreactivity was quantified using
relative fluorescence intensity for each scaffold measured with the aid of a plate reader (Synergy
HT, Bio-Tek Instrument Inc., VT) using techniques familiar to our group. Cells were
counterstained with the nuclear labeling reagent DAPI. Fluorescence values were normalized to
15

cell count for each sample. Cell counts were estimated from DAPI images. Microscopic images
were also obtained for qualitative analysis and comparison.
Statistics
Results are presented as mean ± SEM. A two-way ANOVA with post hoc Tukey test
determined statistical difference for experimental groups in cell viability assay, cytokine assay,
and immunostaining. Student’s T-test was used to determine statistical differences for gene
expression and characterizing the device. P values less than 0.05 indicate significantly different
populations.
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III.

Results

Device Characterization
The first aim was to investigate the critical release height so that the entire shuttle was
subject to linear decelerations and impact durations analogous to that felt during a TBI event.
Impact duration followed an expected trend with the stiff spring (spring constant, 959lbs in-1)
having the shortest impact duration and the flexible spring (90lbs in-1) experiencing the longest
impacts (Table 1). The desired impact durations matching reported physiological conditions were
met using the medium (312lbs in-1) or flexible spring giving impact durations of 9.2 ± 1.2ms and
19.3 ± 0.5ms respectively compared to 1.6 ± 0.3ms for the stiff spring(65). Impact duration was
not affected by the drop height of the shuttle for each spring. Each spring-damped base is
significantly different from the others for impact duration. For each spring, a linear relationship
between peak deceleration and release height exists (Table 1). The flexible spring base reached a
maximum deceleration of 59.1 ± 4.3G when dropped from the highest release point. Though
some reports have described individuals with concussive symptoms after experiencing similar
head decelerations, it does not encompass all individuals who may have a higher threshold to
TBI events. In comparison to the flexible spring, the medium and stiff spring reached maximum
decelerations of 158.2 ± 28.8G and 184.5 ± 26.6G when dropped from the highest release point.
Measured impacts reaching these extreme decelerations are likely to cause symptoms associated
with mild or severe TBI(66). From these characterization trials, we chose to use the medium
spring-damped base. Using the established linear relationship, for all experiments 150G impacts
were obtained by dropping the shuttle from 170cm above the medium spring-damped base.
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Cell Viability
A modified MTT assay was used to quantify cell survival for the experimental group
relative to control groups (Fig 3). Cultures receiving serum and a single impact exhibited the
strongest cell survival, retaining 79.4 ± 6.6% viable cells following a mimetic TBI compared to
the single impact, serum-containing control. Withholding serum from media contributed to a
trend of decreased cell survival as the control and single impacted cultures viable cell counts
were 81.9 ± 11.4% and 81.9 ± 12.1% respectively relative to the serum control. Furthermore, a
second impact significantly decreased viable cell counts to 59.0 ± 4.5% in impacted cultures
supplemented with FBS and 45.4 ± 11.3% in serum-free cultures relative to the control. The
combination of serum-free media and two impacts created a particularly hostile environment for
astrocyte survival. Subsequent long-term studies were consistent with these findings as cultures
withheld from serum were not capable of surviving multiple impacts over a 3-week span (data
not shown).
Gene Expression for Astrocyte Reactivity
We hypothesized astrocytes would increase expression of intermediate filaments GFAP
and vimentin as well as a reported inflammatory marker S100B based on previous in vivo and in
vitro studies(67, 68). Surprisingly, we did not observe an increase in any of these proteins 24
hours after mimetic TBI impacts (Fig 4). Across all conditions, impacted cultures decreased
GFAP and S100B compared to all controls (p<0.0001). The number of impacts or media type did
not have an effect on gene expression. Vimentin expression remained relatively unchanged
compared to controls with the exception of astrocytes receiving serum-containing media and
impacted once decreasing relative gene expression compared to control (p=0.0005). Although
astrocytes withheld from serum receiving a single mimetic TBI upregulated vimentin three-fold,
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this result was not significant from the control (p=0.071). GFAP expression was decreased
across all experimental groups, though only significantly in one impact serum groups (p=0.0011)
and astrocytes withheld from serum receiving two mimetic TBI’s (p=0.0238). S100B was
consistently downregulated by all astrocytes receiving mimetic TBI with cultures receiving two
impacts while withheld from serum displaying the greatest decrease from the control.
Extracellular Matrix Gene Expression
Quantitative reverse transcriptase PCR analysis for structural ECM proteins (Fig 5)
revealed that astrocyte cultures receiving two mimetic TBIs exhibited decreased collagen I
expression (p<0.0001, serum and serum-free). The absence of this observation in the single TBI
condition could indicate a cumulative effect of TBI. Likewise, vesicant (p=0.0040) and neurocan
expression (p=0.0039) decreased for astrocytes impacted twice receiving serum-containing
media. Versican expression was also decreased in the single impact serum-containing media
condition (p=0.0136), indicating a combination of impacts and presence of serum could suppress
versican expression. Neurocan expression levels for all impacted groups decreased compared to
controls, though only significantly as discussed previously. Overall, cultures receiving serumcontaining media and two impacts exhibited reduced expression for ECM proteins, indicating
that astrocytes were producing extracellular matrix at a dampened rate compared to healthy
astrocytes.
Cytokine Secretion
Secreted cytokines regulating ECM turnover and inflammatory cytokines promoting
ECM production were normalized to the viable cells found previously and reported as the
production of cytokine (fg) per astrocyte (Fig 6). Production of TGFB-1 was affected by the
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presence of serum and the number of impacts. Cultures receiving serum-containing media
demonstrated an increased expression of TGFB-1 compared to serum-free cultures.
Interestingly, astrocytes in serum-free media receiving a second impact increased TGFB
production (5.9 ± 0.5 fg cell-1) compared to controls (2.8 ± 0.8 fg cell-1), an expected trend that
was not evident in any other experimental group. A common trend was observed in astrocytes
receiving mimetic TBI decreasing MMP-2 production no matter the media type or number of
impacts. Excluding cultures in serum-free media receiving two impacts, all other impact
conditions decreased MMP-2 by at least half compared to the controls. A significant difference
was not observed in MMP-2 production across number of impacts, but was observed in media
type. One of the inhibitors for MMP-2, TIMP-1, was not affected by injury, number of impacts,
or media type. A miniscule trend of increased TIMP-1 production was observed for most injury
conditions; however, it was not considered a significant increase. Interestingly, TIMP-1
production dominates MMP-2 production in both control and injured astrocytes. TIMP-1 inhibits
MMP-2 in a 1:1 stoichiometric ratio, therefore we quantified the overall inhibitory behavior of
degrading ECM in astrocytes after impacts by investigating the ratio of TIMP-1 to MMP-2
produced by astrocytes. Comparing across media types, cultures receiving serum supplemented
media had a significantly increased TIMP-1/MMP-2 ratio. Within one or two impact groups
there were no statistical differences. In all cohorts, astrocytes impacted with strain experienced a
significant increase in TIMP-1/MMP-2 ratio. This indicates that the combination of serumcontaining media (hemorrhaging) and mechanical stimulation from stretching and impacts can
create an inhibitory environment for the degradation of ECM molecules. An important outcome
of note is the inhibited release of important growth factors bound into the ECM. This could play
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into the somewhat delayed activation of astrocytes after injury as some reports have shown
astrocyte reactivity peaking 4-7 days following injury(69).
Matrix Immunostaining
Using immunostaining, collagen, laminin and CSPG accumulation as well as astrocyte
distribution were evaluated following three weeks of conditioning for both impacted and control
porous polyurethane samples. At the end of the three-week conditioning period, astrocytes were
well-distributed throughout the scaffold for both control and impacted cultures. Quantitative
immuno-histochemical analysis demonstrated that the relative intensities of immunoreactivity to
CSPG, laminin and collagen type I were decreased when compared to un-impacted controls (p <
0.05) Qualitative observations confirmed the quantitative analysis (Fig. 7).
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IV.

Discussion
We present a unique bioreactor subjecting cells to mechanical stimuli that would likely

lead to traumatic brain injury in vivo. The bioreactor provides a model between pure in vitro and
in vivo studies. This bioreactor, to our knowledge, is unique in its ability to simultaneously
expose cells to rapid decelerations, like that in an impact resulting in TBI, while applying biaxial
strain. Moreover, three-dimensional cultures are an important parameter to better mimic the
structure of native tissue capturing cell pathology that may be lost when cultured in 2D (70). The
created bioreactor is advantageous because of the flexibility in experimentation. In this study, we
examined astrocytes cultured in three-dimensional foams; however, the foam can be
interchanged allowing for the study of cells in monolayer, three-dimensional hydrogels or even
organotypic cultures. The bioreactor also has the ability to house primary cells, co-cultures of
astrocytes and neurons, or mixed glial cells. With the complex nature of the bioreactor, the
mechanical stimulation given to individual cells is less understood. The pore structure of each
foam used for cell culture is unique making it impractical to attempt to map stresses and strains
across the entire foam. Additionally, the bioreactor cannot impose angular decelerations often
associated with TBI, nor control strain rate. Both in vivo and in vitro studies alike have
demonstrated a graded injury response to rotational accelerations and strain rates (71, 72). Our
results support astrocyte cultures respond to the mechanical stimulation delivered by the
bioreactor.
Several in vitro models utilize a stretch injury, while neglecting inertial loading on the
cells. Some may argue astrocytes in our bioreactor are incapable of sensing inertial forces
because of the small mass of individual cells (~3x10-9 g) resulting in minute forces on the cell.
Other cell types have exhibited sensitivity to inertial forces. Lung, cardiac, chondrocyte, and
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osteoblasts can modulate ECM production triggered by changes in gravitational forces (73-76).
Applying vibration to mouse vertebrate ex vivo and in vivo stimulated production of extracellular
proteins (77). An in vitro model inducing shear strain on organotypic cultures using inertial
loading increased cell death after injury (78). Because of the sensitivity to Newtonian forces
exhibited in other cell types, it is reasonable to assume astrocytes are capable of sensing and
responding to the decelerations created by our bioreactor modulating the ECM. Under the
experimental regime described above, astrocytes experiencing a 150G deceleration without
biaxial strain altered expression and production of ECM proteins often exhibiting a medial
expression between control and 150G impacts with strain (Supplemental Figure 1).
A hallmark of injury to the central nervous system is reactive astrogliosis, resulting in the
proliferation of astrocytes, increased expression of intermediate filaments after injury, and
increased production of CSPGs (65, 66). We observed forty-eight hours following injury, the
number of viable cells was decreased between 13-55% depending on the media type or impact
number. These values are similar to a stretch injury TBI model performed in vitro (79). We also
report astrocytes decreased GFAP expression after experiencing injury in our model. Zhao et al.
observed decreased immunoreactivity to GFAP in hippocampal astrocytes at acute time points
after TBI in a rat model as well as pronounced astroglial death (80). This could indicate the
injury applied in our model is severe, leaving astrocytes in a damaged state. In comparison,
though not explicitly stated, examination of human cerebellum after TBI displayed correlations
between decreased GFAP expression and increased caspase 3 expression, indicative of cell
apoptosis (81). The decreased expression of S100B can support the claim that astrocytes are
severely damaged in our model as S100B has shown protective effects in neuronal-glial cocultures in vitro after stretch injury (68). Subsequently, high incidences of neuronal death have
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been observed in the same brain regions of astroglial death, which may contribute to the
symptoms associated with TBI (80). An interesting parallel is the decrease in GFAP expression
in astrocytes by depressed and suicidal patients (82, 83). Long term depression and fatigue have
been associated with TBI (84). Although we do not prove that inertial impacts induce these long
term symptoms, it is an observation of note to see similar effects in our experiment.
We observed differences in astrocyte behavior in response to a single injury, two injuries,
and multiple injuries. With respect to ECM expression, a second injury caused significant
decreases in collagen, versican, and neurocan expression in the serum-containing cohort. After
implementing multiple injuries over a three-week time period, we observed decreased ECM
accumulation in injured cultures. These observations suggest the number of impacts may have a
role in how astrocytes modulate the ECM. Multiple impacts have proven translational from in
vitro models to clinical studies. It is widely accepted that individuals with a previous history of
TBI are more susceptible to a second injury, especially in the days following a TBI (85). In an in
vitro stretch injury model, co-cultures of neuronal and glial cells exhibited increased uptake of
propidium iodide after a second injury indicative of cell damage, thus demonstrating how CNS
cells are sensitive to a second injury (86). Likewise, repeated fluid percussion injury subjecting
Long-Evans hooded rats to single or multiple injuries demonstrated behavioral differences,
memory impairment, and increased inflammation short-term and long-term (87). To our
knowledge, this is the first study to investigate the potential cumulative effect of repeated TBI on
the composition and production of extracellular matrix.
The extracellular matrix in the brain is unique in that it is constituted by glycoproteins
(and proteoglycans as opposed to other ECM in tissues having a fibrillary base, typically
collagen. ECM in the brain functions to provide structure to CNS cells, guide axon growth in
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development, form perineuronal nets, and create the blood brain barrier. We examined the
potential fibrotic-like scar formation through the expression of collagen I. Although lacking
fibrillar elements in the central nervous system, astrocytes have been reported to produce
fibrillary collagen in vitro (88). Fibrotic scars have been reported in lesion injuries to CNS,
though this is likely induced by invading meningeal fibroblasts (89). In our study, we found a
suppression in expression of collagen I in cultures receiving multiple injuries. It has been shown
that TGFB-1 increases the production of collagen in astrocyte (89), thus the static nature of
TGFB concentrations between control and TBI groups coupled with the downregulation of
collagen indicates a strong inhibitory pathway is likely in play. Epidermal growth factor, tumor
necrosis factor alpha, and interferon gamma all suppress the production of collagen in astrocytes
in vitro(88). Surprisingly, we did not observe indications of the formation of a glial scar or
increased matrix metalloproteinase activity. This observation is not without precedent, as
versican, neurocan, aggrecan, and phosphacan have been reported to decrease expression near
the injury site of a controlled cortical impact in a rat model (90). It appears clear that the injury
invoked on astrocytes in this model do not initiate the formation of a glial scar. The decreased
extracellular matrix protein expression coupled with suppressed production of MMP-2 indicates
the injured astrocytes are incapable of turning over damaged ECM, while also unable to produce
new ECM. In studies inhibiting MMP-1, synaptogenesis after injury was hampered with MMP-1
inhibited, thus suggesting degenerating ECM after injury is crucial for proper recovery (91). The
suppressed production of MMP-2 could correlate to decreased brain plasticity after TBI. The
negative affects of damaged ECM on cells has been demonstrated in mesenchymal stem cells
when implanted into decellularized scaffolds isolated from cardiac tissue after infraction (92).
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Serum-containing media simulates a disruption of the blood brain barrier after injury,
often scene in moderate to severe cases of TBI. The serum-free condition with the high
mechanical load presents a unique model in that astrocytes experience a severe TBI, yet are not
exposed to the factors that would normally be released upon the disruption of the BBB found
with severe TBI. While serum-containing conditions may be more physiologically relevant,
withholding serum from cultures provides insights to the potential protective effects of the
breakdown of blood vessels and subsequent release of blood upon injury. Serum-free conditions
inherently reduce cell viability, as observed in both TBI and control serum-free conditions;
however, impacting cultures resulted in a far greater reduction in viable cell counts.
Comparatively, as little as 20% cell survival has been reported in astrocytes when deprived of
serum (93). Long-term studies with serum-free cultures confirmed this as cells were incapable of
surviving the impact regiment out to three weeks (data not shown). For ECM expression levels,
we observed increased sensitivity in astrocytes cultured in serum-containing media. One possible
explanation stems from decreased quantities of focal adhesions when astrocytes are deprived of
serum, thus decreasing sensitivity to mechanical stimulation (94).
Overall, we present astrocytes modulate extracellular matrix in response to mechanical
forces. We would be remised to not mention shortcomings in the experimental design. As stated
previously, strain rate and angular accelerations are important parameters that effect the severity
of injury. Unfortunately, with the present design of our device, we are incapable of controlling
strain rate or applying angular accelerations. Further, we did not observe astrocyte behavior after
mild TBI that complemented previous literature, instead likely applying an injury that initiated
cell death and left surviving astrocytes in a severely damaged state. It would be of consequence
to obtain a dose response curve to varying impacts by decreasing the release height of the shuttle.
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We explored astrocytes response at acute time points; however, increasing the time in culture
after injury may reveal alterations in ECM expression indicating the formation of a glial scar or
simply resolving any alterations. A next generation TBI bioreactor is currently being created that
will create a compression injury using a weight dropped onto astrocytes cultured in a hydrogel
that mimics the brain’s mechanical properties (Appendix B Figure 1). The impact has been
characterized for the bioreactor and peak pressures can be estimated from this characterization
(Appendix B Figure 2). The affect of other cell types on astrocytes after injury is not explored
here but could alter the response to injury. To complement this work, understanding the
mechanism in which astrocytes sense and respond to mechanical stimulation is a logical next
step. Increased permeability to calcium is a response to mechanical stimulation in astrocytes,
thus a reasonable target to investigate is a calcium-specific mechanotransducer (95). Influx of
calcium is reported to initiate astrogliosis in the central nervous system, therefore investigating
mechanosensitive calcium channels may increase the understanding of the mechanisms that are
responsible for altering cellular behavior after TBI and may reveal a therapeutic target for
treating injury (96). Preliminary work has begun to investigate the potential role of calcium
permeable channel transient receptor potential cation channel subfamily vanilloid member 4
(TRPV4). As a preliminary step for future research, the influx of calcium has been observed by
astrocytes in response to a TRPV4 agonist (Appendix C Figure 1).
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VI.

Tables and Figures

Figure 1. Bioreactor capable of implementing mechanical stimuli mimicking a traumatic brain
injury. The bioreactor is comprised of four main components: The guide rod (A) constricts the
motion of the bioreactor to the vertical direction. The drop shuttle (B) comprises of two
aluminum plates sandwiching a polypropylene layer. The bottom aluminum plate of the drop
shuttle has six openings for custom made acrylic inserts that apply up to 30% biaxial strain to
cultures (C). A steel plate mounted onto an interchangeable spring creates a spring dampened
impact base prolonging the inertial forces felt by cell cultures (D).
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Figure 2. Fabricated cell culture drums compatible with the mimetic traumatic brain injury
bioreactor. Cell culture drums are fabricated by creating a porous three-dimensional
polyurethane foam and securing the foam to the base of a polypropylene cylinder (A). Biaxial
strain can be applied to the cell culture by inserting an acrylic indenter into the elastic cell culture
(B). The porous polyurethane foam exhibits elastic behavior at low strains and is shown at a
relaxed and stretched state (C,D). Scale bars are representative as follows: Panel A – 1 cm,
Panels C, D – 1 mm.
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Table 1. Comparing bioreactor characteristics for three spring dampened bases
Spring

R2

184.5 ± 26.6
158.2 ± 28.8

Sensitivity
(G cm-1)
0.726
0.734

59.1 ± 4.3

0.213

0.947

Impact Duration (ms)

Peak Deceleration (G)

Stiff
Medium

Spring Constant
(lbs in-1)
959
312

1.6 ± 0.3
9.2 ± 1.2

Flexible

90

19.3 ± 0.5

0.947
0.972
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Figure 3. Relative cell viability for astrocytes 24 hours following mimetic traumatic brain
injury. A modified MTT Assay quantified the short term cell survival for astrocytes cultured
with and without 10% fetal bovine serum following one or two TBI mimetic impacts. Impacted
cultures were made relative to the single impact, serum containing media control (A).
Withholding serum containing media and stimulating astrocytes with one or two TBI-like
impacts decreased astrocyte survival compared to controls. MTT precipitates for controls (B)
indicate strong astrocyte presence located within the seeding zone and little outgrowth into the
surrounding scaffold. Lack of precipitation for impacted cultures (C) demonstrate areas with
lowered cell density. * decrease from control (p<0.05), n=6, mean ± SEM.
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Figure 4. Expression for common markers for reactive gliosis in astrocytes decreased 24 hours
after mechanical stimulation. Vimentin expression (A) was reduced in single impact, serum
containing media cultures, but remained unchanged in all other conditions. Surprisingly, GFAP
expression (B), a hallmark of reactive gliosis, was suppressed in all experimental conditions,
though only significantly in single impact serum containing conditions and two impact serum
withheld conditions. Additionally, S100B expression (C) was decreased across all experimental
conditions. *significant difference from the control group (p<0.05), n=4-5, mean ± SEM.
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Figure 5. Astrocyte gene expression for structural extracellular matrix proteins Collagen I (A),
Neurocan (B), and Versican (C) six hours after mimetic TBI. Expression levels for each sample
group are relative to the control of that group and normalized to the housekeeping gene GAPDH.
Astrocytes cultured in serum containing media and given two mimetic TBIs separated by 24
hours decreased expression of all ECM proteins tested. Additionally, collagen I expression was
decreased in astrocyte cultures receiving two impacts, no matter the media. Versican expression
was decreased in impacted astrocyte cultured in serum containing media. * significant difference
from control group (p<0.05), n=4, mean ± SEM.
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Figure 6. Collection of astrocyte protein secretions for Matrix Metalloproteinase 2 (A), Tissue
inhibitor of metalloproteinases 1 (B), and Transforming Growth Factor Beta 1 (C) 48 hours after
mimetic TBI. Cell culture supernatants were collected 48 hours following the final impact for
each treatment group. Protein concentrations were quantified using a colormetric sandwich
ELISA kit. Concentrations were normalized to the viable cell counts reported previously. The
ratio of the production of TIMP-1 to MMP-2 production (D) indicates an inhibition in the
breakdown of ECM. * significant difference from control group (p<0.05), n=4, mean ± SEM.
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Figure 7. Representative microscopic (100X) images of matrix protein accumulation and
distribution after three weeks in culture for control and impacted scaffolds showing
immunoreactivity for collagen type I (A&B), laminin (C&D), and CSPG (E&F). Quantitative
analysis of extracellular matrix accumulation after three weeks for control and impacted
scaffolds expressed as a percentage of the controls (G) showing that immunoreactivity against
both collagen type I, and laminin CSPG was significantly reduced (* = t-test, p<0.05) in the
impacted group when compared to static controls (mean ± SD, N =6/sample group).
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Supplemental Figure 1. Inertial loading without stain on astrocytes resulted in middling
expression levels for extracellular matrix proteins. Collagen I expression (A) and neurocan
expression (B) were significantly reduced in cultures receiving two 150G impacts without biaxial
strain compared to controls, though not as suppressed as cultures receiving two 150G impacts
with biaxial strain. Versican expression (C) displayed a similar trend in two impact conditions
though was not significant. The ratio of TIMP-1 to MMP-2 (D) found in the media 48 hours after
impact without strain exhibited middling behavior between the control and impact with strain
groups. Error bars are representative of SEM. Asterisks are indicative of significant difference
from the control (p<0.05).
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VII.

Appendix A: Validating Astrocyte Purity through Image Processing

The most common cell type used in studying astrocytes in the literature are primary cultures
isolated from neonatal rat pup cortices. The initial dissociation step results in a culture of mixed
central nervous system cells containing neurons, oligodendrocytes, microglia, and astrocytes. To
isolate astrocytes, a series of shaking steps are performed as astrocytes will adhere strongly to
tissue culture plastic while other central nervous system cells adhere loosely. After shaking,
cultures are passaged with some cells being plated onto coverslips for validation of the purity of
the astrocyte culture. To use in downstream experiments, the user must first validate 90% of cells
in the primary culture are astrocytes and are expressing GFAP, an established marker for
astrocytes.
Cells cultured on coverslips are incubated 1-2 days, fixed, and stained using a fluorescent marker
for GFAP (indirect immunofluorescence staining) and cell nuclei (DAPI). The coverslips are
imaged using fluorescent microscopy obtaining images of cell nuclei and GFAP at the same
locations within the coverslip. Multiple images are obtained from each cover slip (4-5 images,
use 5-6 cover slips). Images are loaded into a single folder and processed through a series of
custom-built Matlab functions.
The number of cells in the image is calculated using watershed segmentation of the DAPI image.
First, the DAPI image is converted to grayscale and enhanced by stretching the contrast across
the dynamic range such that 50% of the pixels have a value of 0 and 1% of the pixels are
saturated. Any nuclei touching the edges of the image are discounted. A Gaussian filter is
applied to the image to eliminate local maxima within nuclei. Otsu’s method converts the
grayscale image into a binary mask by setting a gray level threshold value that sends all pixels
below the threshold to 0 and all pixels above the threshold to saturation. The threshold value is
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determined by minimizing intragroup variation and maximizing intergroup variation. The binary
mask is opened to eliminate small artifacts stemming from debris that are not corresponding to
cells. The mask is applied to the enhanced DAPI image and the local maximum is found within
each cell. The local maximum is isolated and dilated. Inverting the DAPI image with the dilated
local maximum creates nuclei with deep ‘wells’ to improve the performance of watershed
segmentation. Finally, watershed segmentation isolates individual nuclei and the built in Matlab
function bwlabel outputs the number of cells in the image. In determining if the cell is GFAP
positive, a mask is created around each cell nuclei from the DAPI image. The GFAP image is
applied to the mask and the average intensity of the GFAP signal surrounding the nuclei is
determined. If it is greater than the background signal, it is determined that the cell is expressing
GFAP and can be counted as an astrocyte. In all experiments, cell cultures must contain a
minimum of 90% GFAP positive cells.

48

VIII. Appendix B: Next Generation TBI Bioreactor
One can argue that the elastic foam used to culture astrocytes in the traumatic brain injury
bioreactor is not an accurate representation of the extracellular environment. To this end,
modifications to the original device were performed to create an injury model better representing
an insult that would lead to TBI (Figure A1). The modifications are summarized below:
•

Adding a second polypropylene plate to increase the space above the astrocyte culture

•

Replacing the polyurethane foam as a cell substrate by casting astrocytes in an alginate
hydrogel or Matrigel

•

Removing the biaxial stretch injury indenter

•

Adding a Teflon weight that can carry additional stainless steel weights to control the
mass compressing the gel

•

Exchanging the spring base with a foam base to increase impact duration and create a
smooth impact profile

The modifications improve the design of the bioreactor by first culturing cells in an environment
better representing of the soft meshwork of extracellular proteins that make up the central
nervous system. By using a weight to compress the gels, the cells are subject to the deceleration
of the fall, pressure generated by the weight upon deceleration, and stretching as the gel deforms
outwardly to fill the bottom of the cell culture drum in response to the pressure. The device has
been characterized to determine peak decelerations over varying heights at 25cm increments
(Figure A2). Adjusting the weight allows the user to control the pressure applied to the gel by
Newton’s Second Law (Eq. 1) and the definition of pressure (Eq. 2).
𝐹 = 𝑚𝑎

(Eq. 1)
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Peak pressures can be matched to physiological conditions experienced in the brain during an
impact causing TBI. The flexibility of controlling the weight allows the user to investigate the
effects of acceleration and pressure individually. Exchanging the spring base with a foam base
created a smooth bell shaped impact profile similar to that previously reported in the literature
(Figure A2). This is advantageous as the steel plate of the spring base expressed a rapid peak in
deceleration that could be described as a jolt that could be inconsistent between drops.
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Figure B1. Next Generation TBI Bioreactor. The bioreactor consists of an aluminum guide rod
press fit into an aluminum base (A). The design of the shuttle includes two aluminum plates
sandwiching two polypropylene plates with six holes cut out to house cell cultures (B). Cells are
cultured in a polypropylene drum using PDMS as a base secured by a silicone O-ring (C). Cell
cultures are injured using a Teflon weight placed on top of the culture that compresses the
cultures upon impact. The weight can be adjusted by adding stainless steel rings onto the top of
the weight. The base of the drop structure has been modified to have an egg crate base to create
smooth loading and unloading curves. The shuttle can house six separate cultures (E). Astrocytes
are cast into alginate gels (F,G) and are viable within the gels after 96 hours as determined by the
fluorescent marker calcein (H). Scale bar is representative of 100 µm.
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Figure B2. Characterization of Next Gen TBI Bioreactor. Representative curves of eight
different drop heights display physiologically relevant deceleration profiles (A). The average
peak deceleration at each drop height (n=10) established a quadratic relationship between drop
height and peak deceleration (B). The full width half max, full width 20% max, and full width
10% max describe the impact duration (C). The impulse is a measure of change of momentum
and was calculated as the area under the acceleration curve multiplied by the maximum weight
used in the bioreactor (0.383 g) (D). Jerk is the rate of change in acceleration and is calculated as
the change in acceleration from the initial time point to the peak deceleration (E).
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IX.

Appendix C: TRPV4-Mediated Calcium Signaling

Investigating pathways that astrocytes sense and respond to mechanical forces inducing an injury
response is a future goal for our research group. One potential pathway to investigate is through
the mechanically-sensitive calcium channel TRPV4(97). Chondrocytes respond to cyclical
compression in vitro through the TRPV4 channel increasing extracellular matrix production and
altering the mechanical and chemical properties of ECM(98). Knowing the modulations
astrocytes perform in the CNS after insult, we hypothesize that the TRPV4 channel acts as a
mechanotransducer in astrocytes presenting a pathway to sense injury and invoke a calcium
response that triggers an injury cascade. As an initial step, we sought to discover if activating
TRPV4 triggers an inflammatory response or altered extracellular matrix protein production in
astrocytes. As an initial step, a dose response to a chemical agonist, GSK101 (Sigma Aldrich)
was performed to determine concentrations required to invoke a cellular response. Intracellular
calcium concentrations were measured using calcium sensitive Fura-2 dye. Briefly, astrocytes
were seeded onto laminin-coated coverslips and incubated until cells reached confluency. Cells
were rinsed with PBS and incubated in Fura-2 AM (Molecular Probes) for 30 minutes at room
temperature. Cells were again rinsed in PBS and incubated in Tyrode’s Buffer (Sigma Aldrich)
for 15 minutes at room temperature. Fresh Tyrode’s buffer was added prior to imaging. Cells
(n=5) were imaged on an inverted microscope (Motic AE31) with emitted light captured using a
photomultiplier (IonOptix) from excitation wavelengths of 340nm and 380nm sampling at
500Hz. Cultures were imaged for 60 seconds to create a baseline. GSK101 was introduced at
varying concentrations at the 60 second time point and calcium influx was recorded over the
following 440 seconds. Traces were reported as the ratio of emission from 340nm to 380nm
excitation wavelengths with increases in this ratio corresponding to an influx of calcium into the
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cell. The baseline ratio subtracted from the peak 340nm/380nm ratio and normalized to the
baseline provided a unitless measure to compare the calcium response to the introduction of the
agonist. Overall, a trend of increased intracellular calcium concentrations is observed in response
to higher concentrations of GSK101 (Figure B1). However, a one-way ANOVA did not show
significant differences between any treatment groups. Large variances within treatment groups
likely prevented a significant result to be observed.
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Figure C1. Calcium Influx in Astrocytes in Response to TRPV-4 Agonist. Representative
curves of the ratio of emission when excited at 340nm and 380nmfor astrocytes treated with a
TRPV4 agonist GSK101 at 0nM (A), 10nM (B), 100nM (C), 500nM (D), and 1000nM (E).
Increases to the 340nm/380nm corresponds to intracellular increases in calcium stemming from
the opening of the calcium channel TRPV4. The average difference between the peak
340nm/380nm ratio and baseline ratio was normalized to the baseline ratio for each culture
(n=5/concentration) (F). Error bars are representative of SEM.
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X.

Appendix D: IACUC Protocol Approval #15013
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